Drug
Bilpatide clinical trials
Also written RAY1225.
- studies test it
- 11
- open now
- 6
- in phase 3
- 3
- first study started
- 2023
Keep track of what changes. Save the Bilpatide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- RAY1225
- 11
Studies by the year they started
11 studies that test it; most in 2024 (5)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 2
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Bilpatide is read from its arms, and is right about nine times in ten.
Testing it · 11
- Evaluation of the Bioequivalence of RAY1225 Injection in Healthy ParticipantsNot yet recruitingPhase 1Guangdong Raynovent Biotech Co., LtdNCT07827027Written as RAY1225
- A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneNot yet recruitingPhase 3Guangdong Raynovent Biotech Co., LtdNCT07139535Written as RAY1225
- A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 DiabetesNot yet recruitingPhase 3Guangdong Raynovent Biotech Co., LtdNCT07139548Written as RAY1225
- Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are OverweightRecruitingPhase 3Guangdong Raynovent Biotech Co., LtdNCT06893016Written as RAY1225
- A Study of RAY1225 in Participants With Impaired Liver FunctionRecruitingPhase 1Guangdong Raynovent Biotech Co., LtdNCT06577415Written as RAY1225
- A Study of RAY1225 in Participants With ObesityRecruitingPhase 2Guangdong Raynovent Biotech Co., LtdNCT06254261Written as RAY1225
- The Safety, Tolerability and Pharmacokinetic Study of RAY1225CompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT05835752Written as RAY1225
- Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and DigoxinActive, not recruitingPhase 1Guangdong Raynovent Biotech Co., LtdNCT07362030Written as RAY1225
- A Study of RAY1225 in Participants With Type 2 DiabetesActive, not recruitingPhase 2Guangdong Raynovent Biotech Co., LtdNCT06254274Written as RAY1225
- A Study of RAY1225 at Different Injection Sites in Participants With Different Body SizesCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT06577428Written as RAY1225
- A Study of RAY1225 in Participants With Impaired Kidney FunctionCompletedPhase 1Guangdong Raynovent Biotech Co., LtdNCT06613763Written as RAY1225